Clovis Oncology Stock Price - CLVS

Best deals to access real time data!
Canadian Level 1 + USA
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 6.39 ▲ 0.01 (0.16%)
Company Name Stock Ticker Symbol Market Type
Clovis Oncology Inc CLVS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.07 1.11% 6.38 6.58 6.21 6.37 6.31 00:00:01
Bid Price Ask Price Spread Spread % News
6.37 30.00 23.63 78.77% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
18,970 5,362,715 $ 6.34 $ 34,006,305 7,057,293 2.93 - 32.05
Last Trade Time Type Quantity Stock Price Currency
19:59:36 43 $ 6.39 USD

Clovis Oncology Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 349.72M 54.82M $ -368.01M -7.08 - 53.16M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 26.00 3.00%

more financials information »

Clovis Oncology News

Date Time Source News Article
11/15/201916:02Edgar (US Regulatory)Statement of Ownership (sc 13g)
11/14/201914:48Business WireClovis Oncology annonce le remboursement des comprimés de ®..
11/14/201912:08Business WireClovis Oncology kündigt Erstattung für Rubraca®-Tabletten..
11/13/201904:00Business WireClovis Oncology Announces Reimbursement for Rubraca®..
11/08/201916:19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)
11/07/201914:29Edgar (US Regulatory)Quarterly Report (10-q)
11/07/201908:01Edgar (US Regulatory)Current Report Filing (8-k)

Latest CLVS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CLVS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.427.004.296.0721,680,0611.9644.34%
1 Month3.707.002.935.168,811,8082.6872.43%
3 Months5.857.002.934.895,104,5550.539.06%
6 Months18.6319.472.936.793,805,223-12.25-65.75%
1 Year14.9232.052.9311.872,948,234-8.54-57.24%
3 Years34.9099.452.9334.482,063,801-28.52-81.72%
5 Years54.61116.752.9336.041,772,427-48.23-88.32%

Clovis Oncology Description

Clovis Oncology Inc is a biopharmaceutical company. It is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, the EU, and additional international markets. The firm target its development programs for the treatment of specific subsets of cancer populations. Its product candidates include Rucaparib and Lucitanib. Rucaparib is an oral small molecule inhibitor of poly ADP-ribose polymerase, is marketed in the United States for two indications specific to the recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer whereas Lucitanib includes Rucaparib Combo and Nivolumab Combo.
Your Recent History
Clovis Onc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191117 23:22:52